Senova Medical: The American subsidiary plans to borrow up to 1 million US dollars from related parties.

Sinomed Medical announced that its US wholly-owned subsidiary Nova plans to borrow up to $1 million from Well Sun, controlled by the actual controller Sun Jianhua, at an annual interest rate of 3.5% for a term of one year, with the possibility of a written extension. The funds will be used for research and development, clinical trials, and operations. This loan constitutes a related party transaction but not a significant asset restructuring. This proposal has been approved by the board of directors, with related director Sun Jianhua abstaining from voting.